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weight loss. Thirteen of the 16 women who continued to 
have increased intracranial pressure experienced improve-
ment in many of their symptoms, including visual changes 
and tinnitus. This is not surprising, because idiopathic 
intracranial hypertension is probably a chronic disorder 
and lumbar punctures done years after the diagnosis have 
shown raised intracranial pressures.2
What are the implications of these results for practising 
clinicians? The uncontrolled and now prospectively control-
led evidence suggests that weight loss may be an efective 
treatment for patients with idiopathic intracranial hyperten-
sion. Clinicians could recommend the replacement liquid 
diet used by Sinclair and colleagues, or another low energy 
diet, and stress to patients that weight loss may improve 
symptoms and signs. 
This study does not clarify the role of diuretics, espe-
cially acetazolamide, because the authors allowed patients 
to continue taking their usual drugs, and almost half were 
on a steady dose of acetazolamide. A randomised placebo 
controlled trial is now under way in the United States to 
try to answer this question. It is also unknown whether 
weight loss would also improve quality of life and reduce 
depression.
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Corporate responsibility in public health
The government’s invitation to the food industry to fund social marketing  
on obesity is risky
The secretary of state for health in England, Andrew 
La nsley, is certainly getting attention. This week, his 
department is involved in mooted plans to dismember 
the Food Standards Agency (FSA).1 A fortnight ago, at the 
BMA conference Mr Lansley seemed to dismiss the eforts 
of celebrity chef Jamie Oliver to improve school food.2 Last 
week at the Faculty of Public Health conference, he raised 
eyebrows with proposals for the Change4Life social mar-
keting campaign. “We will be progressively scaling back 
the amount of taxpayers’ money spent on Change4Life and 
asking others, including charities, the commercial sector, 
and local authorities, to ill the gap,” he said.3 With chari-
ties and local government seriously squeezed, this will 
hand the campaign over to the food industry.
Change4Life was set up by the recent Labour govern-
ment to encourage the population to “eat well, move 
more, live longer” in an attempt to reduce rocketing rates 
of obesity.4 The Conservatives praised it when they were 
in opposition, but few expected them to hand it over to 
food companies. It is widely accepted that the causes of 
obesity are complex and multifactorial. Putting the food 
industry in the driver’s seat of the policy strand oriented 
at culture change, which prided itself on reaching hard to 
reach social groups, is not only regrettable but puts the fox 
in the hen coop. The food industry spends around £0.5bn 
(€0.6bn; $0.75bn) a year on advertising, often for high 
calorie products.
Mr Lansley’s speech is in danger of embracing self reg-
ulation in the name of iscal constraint. It would h erald 
a return to 1980s rhetoric, when commercial interests 
were in the driving seat of health, even though experi-
ence showed by the 1990s that a more consensual and 
multisectoral approach is needed. When the 2004 World 
Health Assembly Resolution 57.17 urged powerful compa-
nies to join the ight against non-communicable disease, 
responses were later found to be thin, suggesting reluc-
tance to take on any role, let alone responsibility.5 Today, 
a plethora of food company initiatives stress exercise rather 
than eating less by funding sports, free equipment, and 
more. Evidence suggests that no single lever can reverse 
trends.
The sad thing is that Mr Lansley has now enmeshed 
obesity in ideology, with some arguing that it is overweight 
people’s  “own fat fault”—as the current mayor of London 
Boris Johnson once put it—and others arguing that obes-
ity is anywhere from genetically to culturally hard wired. 
Although strong evidence exists on the role of energy dense 
foods and drinks, their ubiquitiousness and grip on mass 
consciousness make their consumption di cult to reduce.6
Obesity has long sufered from policy cacophony, with 
many academic analyses each claiming that their solu-
tion is right.7 In the 2000s, authorities, companies, and 
the public gradually began to realise this, and unpicking 
the complexity has been slow. In 2001, the UK National 
Audit Oice calculated the inancial costs.8 In 2003, the 
chief medical oicer called obesity a “health time bomb.”9 
A parliamentary health committee inquiry in 2004 urged a 
new government framework to give policy coherence.10 The 
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The coalition government’s plans for the NHS in England
Much more work is needed to ensure they can deliver improvements in care
The coalition government’s plans for the future of health 
care in England herald fundamental changes to both the 
anatomy and physiology of the NHS.1 These changes take 
forward reforms set out by the Labour government led by 
Tony Blair in 2002 and developed further by Ara Darzi 
in 2008, but they are much more ambitious and risky.2 3
The anatomy of the NHS will be afected by the setting 
up of an independent commissioning board, the abolition 
of strategic health authorities and primary care trusts, 
and a new role for local authorities in promoting public 
health. Its physiology will be altered by the use of markets 
instead of targets to drive improvements in performance.
On the provider side of the market, NHS foundation 
trusts will have greater autonomy, and independent sec-
tor providers will be encouraged to compete for patients. 
On the commissioner side, groups of general practices 
will take responsibility for most of the NHS budget and 
use their clinical expertise to bring about improvements 
in care. The operation of the market will be overseen by 
a new economic regulator. Its role will be to promote 
chief scientist’s Foresight oice agreed in 2007, producing 
even stronger data and warnings of costs.11 This protracted 
learning process inally yielded urgency, leadership, and 
budgets (£0.3bn over three years). Healthy Weight Healthy 
Lives was a cross departmental strategy launched in 2008, 
and Change4Life formed part of this strategy.
The role and inluence of food companies are important. 
They need to move further in improving diets, not only by 
taking action on ingredients such as the type of fats and 
levels of salt and sugar, but also the size of portions and the 
role of advertising, particularly when targeted at children. 
But the question is: should companies dominate policy 
and delivery? Most policy makers favour equal partner-
ships. The European Commission is currently supporting 
a 28 country project to examine the ways in which food 
companies, governments, and civil society are working 
cooperatively to tackle obesity. But corporate responsibil-
ity should not dominate policy.
The chief scientist’s multidisciplinary Foresight team 
conirmed that obesity is the equivalent of public health’s 
climate change, a problem that relects multiple rather 
than single drivers. Action is needed on all fronts. Supply 
chains overproduce food; prices send inappropriate sig-
nals; cultural messages are warped; the physical environ-
ment fails to encourage physical activity; and cheap fossil 
fuels encourage cars over bicycles. Hence the verdict that 
obesity is a logical physiological response to an obesogenic 
environment.12
Mr Lansley’s thoughts imply that a combination of 
corporate and individual responsibility will do the trick. 
This is risky thinking. The Healthy Weight, Healthy Lives 
programme he inherits did not underplay the personal 
responsibility that individuals have for their weight, and 
it recognised that without system-wide action there would 
be little hope in turning around what already seemed to be 
the worst public health crisis since HIV.
All of this is well known but worth rehearsing for the 
new secretary of state. He would do well to pause. Many 
countries, not least across the EU, see the United Kingdom 
as setting a lead on tackling obesity; they’ll be alarmed at 
this faltering leadership. The real worry is that the changes 
to Change4Life are a harbinger of changes elsewhere, such 
as the downgrading of Healthy Weight Healthy Lives in its 
entirety and the curtailing of the Food Standards Agency’s 
“tough but kind” eforts to change the behaviour of food 
companies. If the talk of axing the entire FSA turns out to 
be true, this could set back the public health cause. Ini-
tially charged with tackling the UK’s food safety crisis in 
the 1980s-1990s, the FSA has begun to take on a broader 
consumer mantle. It is this that some—not all—voices in 
the food industry have disliked. Ironically, by showing his 
hand early, Mr Lansley has done public health proponents 
a service. Tackling obesity requires bold eforts to shift how 
we live, but iscal constraint should not be an excuse for 
ideological reassertion.
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